Table 1.
Participant characteristics at time of randomization in this study by treatment group
| PLGS (N = 55) | CLC (N = 54) | |
|---|---|---|
| Age (years) | 34 ± 17 | 32 ± 14 |
| Diabetes duration (years), median (IQR) | 16 (7, 31) | 18 (8, 29) |
| BMI (kg/m2), median (IQR) | 25 (23, 29) | 26 (23, 30) |
| Sex, female | 25 (45) | 28 (52) |
| Race, white* | 46 (87) | 46 (87) |
| Hispanic or Latino ethnicity | 7 (13) | 6 (11) |
| Annual household income† | ||
| <$50,000 | 5 (11) | 5 (12) |
| $50,000 to <$100,000 | 13 (30) | 8 (19) |
| ≥$100,000 | 26 (59) | 29 (69) |
| Highest education level‡ | ||
| Less than a bachelor’s degree | 8 (15) | 8 (15) |
| Bachelor’s degree | 23 (42) | 26 (49) |
| Advanced degree | 24 (44) | 19 (36) |
| Insurance, private§ | 51 (94) | 49 (92) |
| HbA1c, % (mmol/mol) | ||
| Baseline of the preceding RCT | 7.3 ± 0.8 | 7.5 ± 1.1 |
| (56 ± 8.7) | (58 ± 12.0) | |
| At randomization for this trial | 7.1 ± 0.8 | 7.0 ± 0.8 |
| (54 ± 8.7) | (53 ± 8.7) | |
| CGM in TIR 70–180 mg/dL in the preceding RCT (%) | ||
| Baseline | 61.8 ± 16.7 | 59.1 ± 18.3 |
| During 26 weeks | 71.3 ± 12.7 | 71.6 ± 10.7 |
Data are mean ± SD or n (%) unless otherwise indicated.
*
Two patients in the PLGS group and one in the CLC did not provide race information.
†
There were 11 patients in the PLGS group and 12 in the CLC group who did not provide income information.
‡
The highest level completed by the patient or by the primary caregiver if the patient was <18 years old. One patient in the CLC group did not provide education information.
§
One patient in the PLGS group and one in the CLC group did not provide insurance information.